Summit Therapeutics Inc. Common Stock
SMMT Real Time Price USDRecent trades of SMMT by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by SMMT's directors and management
Government lobbying spending instances
-
$30,000 Aug 03, 2020 Issue: Pharmacy
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Antibacterial compounds Sep. 19, 2017
-
Patent Title: Antibacterial compounds Apr. 19, 2016
-
Patent Title: Compounds for the treatment of Mar. 08, 2016
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of SMMT in WallStreetBets Daily Discussion
Recent insights relating to SMMT
Recent picks made for SMMT stock on CNBC
ETFs with the largest estimated holdings in SMMT
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view SMMT Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.